Sj??c;gren's Syndrome: Autoimmune Epithelitis, Clinical Immunology and Immunopathology, vol.72, issue.2, pp.162-165, 1994. ,
DOI : 10.1006/clin.1994.1123
The mosaic of autoimmunity, Autoimmunity Reviews, vol.7, issue.3, pp.161-163, 2008. ,
DOI : 10.1016/j.autrev.2007.11.021
Characteristics of the minor salivary gland infiltrates in Sj??gren's syndrome, Journal of Autoimmunity, vol.34, issue.4, pp.400-407, 2010. ,
DOI : 10.1016/j.jaut.2009.10.004
BAFF-induced changes in B cell antigen receptor???containing lipid rafts in Sj??gren's syndrome, Arthritis & Rheumatism, vol.170, issue.1, pp.115-126, 2006. ,
DOI : 10.1002/art.21478
Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sj??gren's syndrome., Journal of Clinical Investigation, vol.102, issue.5, pp.938-946, 1998. ,
DOI : 10.1172/JCI3234
Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sj??gren's syndrome, Arthritis & Rheumatism, vol.44, issue.11, pp.3187-3201, 2003. ,
DOI : 10.1002/art.11311
Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sj??gren's syndrome, Arthritis & Rheumatism, vol.115, issue.6, pp.1773-1784, 2005. ,
DOI : 10.1002/art.21062
Immunopathogenesis of primary Sj??gren??s syndrome: implications for disease management and therapy, Current Opinion in Rheumatology, vol.17, issue.5, pp.558-565, 2005. ,
DOI : 10.1097/01.bor.0000172801.56744.c3
TH1-TH2: a Procrustean paradigm, Nature Immunology, vol.4, issue.6, pp.503-505, 2003. ,
DOI : 10.1038/ni0603-503
TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional Properties, Annual Review of Immunology, vol.7, issue.1, pp.145-173, 1989. ,
DOI : 10.1146/annurev.iy.07.040189.001045
Interleukin-17 and Type 17 Helper T Cells, New England Journal of Medicine, vol.361, issue.9, pp.888-898, 2009. ,
DOI : 10.1056/NEJMra0707449
Regulatory T Cells and Immune Tolerance, Cell, vol.133, issue.5, pp.775-787, 2008. ,
DOI : 10.1016/j.cell.2008.05.009
The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sj??gren's syndrome, Autoimmunity Reviews, vol.9, issue.9, pp.609-614, 2010. ,
DOI : 10.1016/j.autrev.2010.05.007
Significance of B cells and B cell clonality in Sj??gren's syndrome, Arthritis & Rheumatism, vol.52, issue.9, pp.2605-2610, 2010. ,
DOI : 10.1002/art.27564
Reciprocal regulation of polarized cytokine production by eff ector B and T cells, Nature Immunology, vol.1, issue.6, pp.475-482, 2000. ,
DOI : 10.1038/82717
Regulatory B lymphocytes in humans: A potential role in autoimmunity, Arthritis & Rheumatism, vol.54, issue.7, pp.1900-1906, 2008. ,
DOI : 10.1002/art.23487
B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling, Current Opinion in Immunology, vol.19, issue.3, pp.327-336, 2007. ,
DOI : 10.1016/j.coi.2007.04.008
Circulating Cytokines in Primary Sjogren's Syndrome Determined by a Multiplex Cytokine Array System, Scandinavian Journal of Immunology, vol.54, issue.6, pp.592-599, 2004. ,
DOI : 10.1046/j.1365-3083.1998.00440.x
Th1 and Th2 Lymphocytes in Autoimmune Disease, Critical Reviews in Immunology, vol.25, issue.2, pp.75-102, 2005. ,
DOI : 10.1615/CritRevImmunol.v25.i2.10
Immune Interferon in the Circulation of Patients with Autoimmune Disease, New England Journal of Medicine, vol.301, issue.1, pp.5-8, 1979. ,
DOI : 10.1056/NEJM197907053010102
Altered frequency of type-1 cytokine secreting cells in the peripheral blood of patients with primary Sjögren's syndrome, J Rheumatol, vol.25, pp.89-93, 1998. ,
CYTOKINE mRNA EXPRESSION IN THE LABIAL SALIVARY GLAND TISSUES FROM PATIENTS WITH PRIMARY SJ??GREN'S SYNDROME, Rheumatology, vol.34, issue.4, pp.326-333, 1995. ,
DOI : 10.1093/rheumatology/34.4.326
Overexpression of phosphorylated STAT-1?? in the labial salivary glands of patients with Sj??gren's syndrome, Arthritis & Rheumatism, vol.93, issue.11, pp.3476-3484, 2006. ,
DOI : 10.1002/art.22176
Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjogren's syndrome compared with non-Sjogren's sicca syndrome, Annals of the Rheumatic Diseases, vol.64, issue.10, pp.1474-1479, 2005. ,
DOI : 10.1136/ard.2004.031781
The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren???s syndrome, Clinical & Experimental Immunology, vol.72, issue.(Suppl. 1), pp.562-568, 2002. ,
DOI : 10.1046/j.1365-2249.2002.01869.x
Increased circulating levels and salivary gland expression of IL-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal infl ammatory infi ltrate, Arthritis Research & Therapy, vol.6, issue.5, pp.447-456, 2004. ,
DOI : 10.1186/ar1209
Identification of IL-18 and Th17 Cells in Salivary Glands of Patients with Sjogren's Syndrome, and Amplification of IL-17-Mediated Secretion of Inflammatory Cytokines from Salivary Gland Cells by IL-18, The Journal of Immunology, vol.181, issue.4, pp.2898-2906, 2008. ,
DOI : 10.4049/jimmunol.181.4.2898
Interleukin 18: a pleiotropic participant in chronic inflammation, Immunology Today, vol.21, issue.7, pp.312-315, 2000. ,
DOI : 10.1016/S0167-5699(00)01648-0
Role of Th1 and Th17 cells in organ-specific autoimmunity, Journal of Autoimmunity, vol.31, issue.3, pp.252-256, 2008. ,
DOI : 10.1016/j.jaut.2008.04.017
Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sj??gren's syndrome: Findings in humans and mice, Arthritis & Rheumatism, vol.54, issue.3, pp.734-743, 2008. ,
DOI : 10.1002/art.23214
Proinflammatory T helper type 17 cells are effective B-cell helpers, Proceedings of the National Academy of Sciences, vol.107, issue.32, pp.14292-14297, 2010. ,
DOI : 10.1073/pnas.1009234107
Systemic and Local Interleukin-17 and Linked Cytokines Associated with Sj??gren???s Syndrome Immunopathogenesis, The American Journal of Pathology, vol.175, issue.3, pp.1167-1177, 2009. ,
DOI : 10.2353/ajpath.2009.090319
Two Functional Subsets of FOXP3+ Regulatory T Cells in Human Thymus and Periphery, Immunity, vol.28, issue.6, pp.870-880, 2008. ,
DOI : 10.1016/j.immuni.2008.03.018
CD4 CD25 regulatory T cells are not impaired in patients with primary Sj??gren's syndrome, Journal of Autoimmunity, vol.24, issue.3, pp.235-242, 2005. ,
DOI : 10.1016/j.jaut.2005.01.015
Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sj??gren's syndrome, Lupus, vol.24, issue.1, pp.34-39, 2008. ,
DOI : 10.1177/0961203307085248
Foxp3+ T-regulatory cells in Sjögren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors ,
http://arthritis-research.com/content, p.227227, 2011. ,
The weight of interleukin-6 in B cell-related autoimmune disorders, Journal of Autoimmunity, vol.32, issue.3-4, pp.206-210, 2009. ,
DOI : 10.1016/j.jaut.2009.02.013
Interleukin 6: from bench to bedside, Nature Clinical Practice Rheumatology, vol.28, issue.11, pp.619-626, 2006. ,
DOI : 10.1038/ncprheum0338
Interleukin 17???producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice, Nature Immunology, vol.1, issue.2, pp.166-175, 2008. ,
DOI : 10.1038/ni1552
Ectopic Germinal Centers Are Rare in Sjogren's Syndrome Salivary Glands and Do Not Exclude Autoreactive B Cells, The Journal of Immunology, vol.182, issue.6, pp.3540-3547, 2009. ,
DOI : 10.4049/jimmunol.0803588
IL-6 Contributes to the Expression of RAGs in Human Mature B Cells, The Journal of Immunology, vol.179, issue.10, pp.6790-6798, 2007. ,
DOI : 10.4049/jimmunol.179.10.6790
Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression, Clinical & Experimental Immunology, vol.63, issue.Suppl. 1, pp.75-83, 1992. ,
DOI : 10.1111/j.1365-2249.1992.tb03042.x
Increased expression of interleukin-7 in labial salivary glands of patients with primary Sj??gren's syndrome correlates with increased inflammation, Arthritis & Rheumatism, vol.56, issue.Suppl, pp.969-977, 2010. ,
DOI : 10.1002/art.27318
Cutting Edge: The Development of IL-4-Producing B Cells (B Effector 2 Cells) Is Controlled by IL-4, IL-4 Receptor ??, and Th2 Cells, The Journal of Immunology, vol.175, issue.11, pp.7103-7107, 2005. ,
DOI : 10.4049/jimmunol.175.11.7103
Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-?? receptor-IgG1 fusion protein, Proceedings of the National Academy of Sciences, vol.93, issue.23, pp.13102-13107, 1996. ,
DOI : 10.1073/pnas.93.23.13102
Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs, Journal of Experimental Medicine, vol.184, issue.5, pp.1999-2006, 1996. ,
DOI : 10.1084/jem.184.5.1999
Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice, European Journal of Immunology, vol.16, issue.8, pp.2033-2042, 1997. ,
DOI : 10.1002/eji.1830270830
The Sequential Role of Lymphotoxin and B Cells in the Development of Splenic Follicles, The Journal of Experimental Medicine, vol.254, issue.7, pp.997-1007, 1998. ,
DOI : 10.1084/jem.185.12.2111
Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sj??gren syndrome in salivary glands of non-obese diabetic mice, Arthritis Research & Therapy, vol.11, issue.1, p.24, 2009. ,
DOI : 10.1186/ar2617
A Role for Lymphotoxin in Primary Sjogren's Disease, The Journal of Immunology, vol.185, issue.10, pp.6355-6363, 2010. ,
DOI : 10.4049/jimmunol.1001520
In human B cells, IL-12 triggers a cascade of molecular events similar to Th1 commitment, Blood, vol.102, issue.12, pp.4084-4089, 2003. ,
DOI : 10.1182/blood-2003-02-0518
Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sj??gren's syndrome: Correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development, Arthritis & Rheumatism, vol.405, issue.12, pp.3977-3988, 2007. ,
DOI : 10.1002/art.23073
Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sj????gren's syndrome, Arthritis & Rheumatism, vol.130, issue.12, pp.3633-3641, 2009. ,
DOI : 10.1002/art.24980
Polarization of B effector cells in Sj??gren's syndrome, Autoimmunity Reviews, vol.6, issue.7, pp.427-431, 2007. ,
DOI : 10.1016/j.autrev.2007.01.010
Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sj??gren's syndrome, Arthritis & Rheumatism, vol.42, issue.Suppl, pp.2160-2171, 2002. ,
DOI : 10.1002/art.10445
Abnormalities in peripheral B cell memory of patients with primary Sj??gren's syndrome, Arthritis & Rheumatism, vol.416, issue.Suppl 1, pp.1897-1908, 2004. ,
DOI : 10.1002/art.20276
What do we know about memory B cells in primary Sj??gren's syndrome?, Autoimmunity Reviews, vol.9, issue.9, pp.600-603, 2010. ,
DOI : 10.1016/j.autrev.2010.05.005
Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sj??gren's syndrome, Arthritis & Rheumatism, vol.13, issue.7, pp.2109-2119, 2005. ,
DOI : 10.1002/art.21129
?Lymphoid? chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sj???gren's syndrome patients: Possible participation in lymphoid structure formation, Arthritis & Rheumatism, vol.168, issue.2, pp.408-418, 2001. ,
DOI : 10.1002/1529-0131(200102)44:2<408::AID-ANR60>3.0.CO;2-0
CXCR4-CXCL12-Dependent Inflammatory Network and Endothelial Progenitors, Current Medicinal Chemistry, vol.17, issue.27, pp.3019-3029, 2010. ,
DOI : 10.2174/092986710791959792
The Transcription Factor GATA-3 Is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T Cells, Cell, vol.89, issue.4, pp.587-596, 1997. ,
DOI : 10.1016/S0092-8674(00)80240-8
APRIL: A Tutorial on B Cell Survival, Annual Review of Immunology, vol.21, issue.1, pp.231-264, 2003. ,
DOI : 10.1146/annurev.immunol.21.120601.141152
Association of BAFF/BLyS overexpression and altered B cell differentiation with Sj??gren???s syndrome, Journal of Clinical Investigation, vol.109, issue.1, pp.59-68, 2002. ,
DOI : 10.1172/JCI0214121
Excess BAFF Rescues Self-Reactive B Cells from Peripheral Deletion and Allows Them to Enter Forbidden Follicular and Marginal Zone Niches, Immunity, vol.20, issue.6, pp.785-798, 2004. ,
DOI : 10.1016/j.immuni.2004.05.010
Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sj???gren's syndrome, Arthritis & Rheumatism, vol.83, issue.12, pp.2238-2248, 1998. ,
DOI : 10.1002/1529-0131(199812)41:12<2238::AID-ART20>3.0.CO;2-V
Lymphotoxin ??/?? and Tumor Necrosis Factor Are Required for Stromal Cell Expression of Homing Chemokines in B and T Cell Areas of the Spleen, The Journal of Experimental Medicine, vol.209, issue.2, pp.403-412, 1999. ,
DOI : 10.1084/jem.183.4.1461
Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells, European Journal of Immunology, vol.154, issue.9, pp.2504-2514, 2006. ,
DOI : 10.1002/eji.200636270
Human T cells induce their own regulation through activation of B cells, Journal of Autoimmunity, vol.36, issue.3-4, pp.228-238, 2011. ,
DOI : 10.1016/j.jaut.2011.01.005
URL : https://hal.archives-ouvertes.fr/hal-00771265
Increased CD4+Foxp3+ T Cells in BAFF-Transgenic Mice Suppress T Cell Effector Responses, The Journal of Immunology, vol.182, issue.2, pp.793-801, 2009. ,
DOI : 10.4049/jimmunol.182.2.793
Is periodontal disease mediated by salivary baff in sj??gren's syndrome?, Arthritis & Rheumatism, vol.174, issue.8, pp.2411-2414, 2005. ,
DOI : 10.1002/art.21205
The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome, Annals of the Rheumatic Diseases, vol.62, issue.2, pp.168-171, 2003. ,
DOI : 10.1136/ard.62.2.168
Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis, J Rheumatol, vol.35, pp.1256-1264, 2008. ,
B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time, Lupus, vol.17, issue.9, pp.570-576, 2006. ,
DOI : 10.1177/0961203306071871
The Reduction of Serum B-Lymphocyte Activating Factor levels following Quinacrine Add-On Therapy in Systemic Lupus Erythematosus, Scandinavian Journal of Immunology, vol.23, issue.4, pp.299-303, 2006. ,
DOI : 10.1186/ar1222
The late news on baff in autoimmune diseases, Autoimmunity Reviews, vol.9, issue.12, pp.804-806, 2010. ,
DOI : 10.1016/j.autrev.2010.06.011
URL : https://hal.archives-ouvertes.fr/hal-01150971
New ELISA for B Cell-Activating Factor, Clinical Chemistry, vol.55, issue.10, pp.1843-1851, 2009. ,
DOI : 10.1373/clinchem.2009.129940
URL : https://hal.archives-ouvertes.fr/hal-01103760
Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis, Proceedings of the National Academy of Sciences, vol.105, issue.39, pp.14993-14998, 2008. ,
DOI : 10.1073/pnas.0806044105
Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling, Cytokine, vol.41, issue.2, pp.105-113, 2008. ,
DOI : 10.1016/j.cyto.2007.09.015
Act1, a Negative Regulator in CD40- and BAFF-Mediated B Cell Survival, Immunity, vol.21, issue.4, pp.575-587, 2004. ,
DOI : 10.1016/j.immuni.2004.09.001
http://arthritis-research.com/content, p.227227, 2011. ,
The adaptor Act1 is required for interleukin 17???dependent signaling associated with autoimmune and inflammatory disease, Nature Immunology, vol.13, issue.3, pp.247-256, 2007. ,
DOI : 10.1074/jbc.273.7.4112
Induction of interferon-?? production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG, Arthritis & Rheumatism, vol.9, issue.8 Suppl, pp.1861-1872, 2004. ,
DOI : 10.1002/art.20254
Activation of the type I interferon pathway in primary Sjogren???s syndrome, Journal of Autoimmunity, vol.35, issue.3, pp.225-231, 2010. ,
DOI : 10.1016/j.jaut.2010.06.012
Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome, Proceedings of the National Academy of Sciences, vol.103, issue.8, pp.2770-2775, 2006. ,
DOI : 10.1073/pnas.0510837103
Epigenetics and Autoimmunity, with Special Emphasis on Methylation, The Keio Journal of Medicine, vol.60, issue.1, pp.10-16, 2011. ,
DOI : 10.2302/kjm.60.10
URL : https://hal.archives-ouvertes.fr/hal-00771236
Identification of transitional type II B cells in the salivary glands of patients with Sj??gren's syndrome, Arthritis & Rheumatism, vol.1050, issue.7, pp.2280-2288, 2006. ,
DOI : 10.1002/art.21936
Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sj??gren's syndrome, Arthritis & Rheumatism, vol.54, issue.4, pp.1134-1144, 2007. ,
DOI : 10.1002/art.22458
The anti-CD20 antibody rituximab reduces the Th17 cell response, Arthritis & Rheumatism, vol.318, issue.6, pp.1507-1516, 2011. ,
DOI : 10.1002/art.30314
B-cell tolerance breakdown in Sj??gren's Syndrome: Focus on BAFF, Autoimmunity Reviews, vol.9, issue.9, pp.604-608, 2010. ,
DOI : 10.1016/j.autrev.2010.05.006
Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway, Blood, vol.103, issue.2, pp.679-688, 2004. ,
DOI : 10.1182/blood-2003-02-0540
B-cell-directed therapies for autoimmune disease, Nature Reviews Rheumatology, vol.56, issue.8, pp.433-441, 2009. ,
DOI : 10.1038/nrrheum.2009.141
Rituximab treatment in patients with primary Sj??gren's syndrome: An open-label phase II study, Arthritis & Rheumatism, vol.44, issue.9, pp.2740-2750, 2005. ,
DOI : 10.1002/art.21260
Saraux A: Improvement of Sjögren's syndrome after two infusions of rituximab (anti-CD20) Arthritis Rheum, pp.310-317, 2007. ,
Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study, Annals of the Rheumatic Diseases, vol.67, issue.11, pp.1541-1544, 2008. ,
DOI : 10.1136/ard.2007.083865
B-cell-directed therapies for autoimmune disease, Nature Reviews Rheumatology, vol.56, issue.8, pp.433-441, 2009. ,
DOI : 10.1038/nrrheum.2009.141
http://arthritis-research.com/content, p.227227, 2011. ,